Monkeypox is a zoonosis first described in a human patient in 1970, when the virus was isolated from a 9-month-old patient with smallpox suspicion in the Democratic Republic of Congo. It is a neglected endemic zoonotic disease in the tropical rainforest regions of Central and West Africa. In 2003, the first outbreak of Monkeypox virus [...]
Vitassay Healthcare attended AACC 2022 at McCormick Place Convention Center (Chicago, US). Our team was able to introduce the new turbidimetry, CLIA and qPCR products to our customers from all over the world. In addition, two posters were presented in which the advantages of Vitassay qPCR were highlighted. We are already preparing the next exhibition: [...]
Vitassay will be present in the next edition of the AACC exhibition, which will be held in Chicago on 26th, 27th and 28th July. The firm will present its new products for the diagnosis of infectious diseases, with special attention to the latest developments of qPCR product and the new family of CLIA diagnostic kits, [...]
From January 24 to 27, Vitassay will be present once again at the MEDLAB Middle East Exhibition at Dubai. Again, the greatest precautionary measures have been taken so that visitors and exhibitors enjoy a positive and safe experience. Vitassay Healthcare, faithful to this appointment, will be present at its stand number Z5.F01, showing its entire [...]
After the 2020 stoppage due to the COVID-19 pandemic, Vitassay will once again be present at MEDICA, the largest and most important world fair for the medical sector, which brings together more than 6,000 exhibitors from five continents. Vitassay recovers the space it already had in 2019, where it will present its latest innovations in [...]
Next September 28, 29 and 30, Vitassay will be present in the new AACC edition that, after a blank year due to a pandemic, returns with force to Atlanta. The firm will present its new releases focused on the diagnosis of infectious diseases, with special attention to the latest developments for the SARS-CoV-2 detection and [...]
New Real-time PCR kit for the qualitative detection of RNA from genetic mutations in the S gene (P681R, L452R and E484Q) in positive SARS-CoV-2 respiratory samples. Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant genetic diversity [...]
From June 21 to 24, Vitassay will be exhibiting its latest releases at the MEDLAB Middle East 2021 Exhibition. The SARS-CoV-2 pandemic forced to delay this appointment, which usually takes place at the beginning of the year. This time, the greatest precautionary measures have been taken so that visitors and exhibitors will enjoy a positive [...]
The new Vitassay Real Time PCR allows the qualitative detection of SARS-CoV-2 and the HV 69/70 deletion of the S gene for SARS-CoV-2 in respiratory samples. Several SARS-CoV-2 variants of concern (VOC) have emerged in the past months and monitoring them in all countries is key. The United Kingdom (UK) has detected a new [...]
[fusion_builder_container hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" border_style="solid" flex_column_spacing="0px" type="legacy"][fusion_builder_row][fusion_builder_column type="1_1" type="1_1" background_position="left top" background_color="" border_color="" border_style="solid" border_position="all" spacing="yes" background_image="" background_repeat="no-repeat" padding_top="" padding_right="" padding_bottom="" padding_left="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="small-visibility,medium-visibility,large-visibility" center_content="no" last="true" min_height="" hover_type="none" link="" first="true"][fusion_text]The new Vitassay SARS-CoV-2 + Flu A + B + RSV [...]
